← Leaderboards
Giuseppe Cullaro
University Of California, San Francisco
$649,500
Attributed
$649,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $163.5K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$649,500 · 1
By mechanism
K23$649,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Carmen Alicia Peralta$3,346,608
- Trever G Bivona$22,714,857
- Harold A Chapman$29,865,601
- Edilberto Amorim$1,148,146
- Vasantha Kolavennu Jotwani$2,579,740
Others in their field
Other Rising Stars on “Clinical Risk”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Gary Mays · Axle Informatics, Llc$50,929,860
- Suma Babu · Massachusetts General Hospital$20,824,388
- Sabrina Paganoni · Massachusetts General Hospital$20,824,388
- Bambra Stokes · Ppd Development Lp$17,155,112
- Jennifer Lee O'Brien · University Of South Florida$15,110,862
Research focus
Clinical RiskComplicationCirrhosisClinical ResearchCohortCommunitiesAdultAwardAffectBiological MarkersBiological Specimen BanksAging PopulationAlbuminsCollaborationsAmericanBiometryCalibrationCaliforniaCareerCareer DevelopmentCause Of DeathCessation Of LifeChronic Kidney FailureCost
Grant awards (5)
Application of Novel Biomarkers of Renal Health in Cirrhosis Patients to Stratify Risk of Acute Kidney Injury Occurrence and Reversibility$162,000
K23 · FY2025 · DK · contact PI
Application of Novel Biomarkers of Renal Health in Cirrhosis Patients to Stratify Risk of Acute Kidney Injury Occurrence and Reversibility$98,375
K23 · FY2024 · DK · contact PI
Application of Novel Biomarkers of Renal Health in Cirrhosis Patients to Stratify Risk of Acute Kidney Injury Occurrence and Reversibility$63,625
K23 · FY2024 · DK · contact PI
Application of Novel Biomarkers of Renal Health in Cirrhosis Patients to Stratify Risk of Acute Kidney Injury Occurrence and Reversibility$162,000
K23 · FY2023 · DK · contact PI
Application of Novel Biomarkers of Renal Health in Cirrhosis Patients to Stratify Risk of Acute Kidney Injury Occurrence and Reversibility$163,500
K23 · FY2022 · DK · contact PI